Skip to main content
SpringerLink
Log in

Treat Clostridium difficile infection in the elderly based on disease severity and history of recurrence

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

Abstract

Advanced age is a significant risk factor for the development and recurrence of Clostridium difficile infection (CDI) and is associated with increased mortality. A timely diagnosis, appropriate treatment (based on disease severity, history of recurrence and cost) with vancomycin, metronidazole and/or fidaxomicin, and effective infection control are crucial for optimizing the care of elderly patients with CDI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31(5):431–55.

    Article  PubMed  Google Scholar 

  2. To KB, Napolitano LM. Clostridium difficile infection: update on diagnosis, epidemiology, and treatment strategies. Surg Infect. 2014;15(5):490–502.

    Article  Google Scholar 

  3. Abou Chakra CN, Pepin J, Sirard S, et al. Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic review. PloS One. 2014;9:e98400.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Lessa FC, Mu Y, Bamberg WM, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372(9):825–34.

    Article  CAS  PubMed  Google Scholar 

  5. Mizusawa M, Doron S, Gorbach S. Clostridium difficile diarrhea in the elderly: current issues and management options. Drugs Aging. 2015;32(8):639–47.

    Article  PubMed  Google Scholar 

  6. Strausbaugh LJ, Sukumar SR, Joseph CL, et al. Infectious disease outbreaks in nursing homes: an unappreciated hazard for frail elderly persons. Clin Infect Dis. 2003;36(7):870–6.

    Article  PubMed  Google Scholar 

  7. Chait MM. The new era of C. difficile-associated diarrhea. Ann Longterm Care. 2008;16(7):25–31.

    Google Scholar 

  8. Centers for Disease Control and Prevention. Clostridium difficle infection. http://www.cdc.gov/HAI/organisms/cdiff/Cdiff_infect.html. Accessed 14 Jan 2016.

  9. Debast SB, Bauer MP, Kuijper EJ. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect. 2014;20(Suppl 2):1–26.

    Article  CAS  PubMed  Google Scholar 

  10. Gould CV, McDonald LC. Bench-to-bedside review: Clostridium difficile colitis. Crit Care. 2008;12(1):203–10.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Olson MM, Shanholtzer CJ, Lee JT, et al. Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982–1991. Infect Control Hosp Epidemiol. 1994;15(6):371–81.

    Article  CAS  PubMed  Google Scholar 

  12. Mullane KM, Miller MA, Weiss K, et al. Efficacy of fidaxomicin versus vancomycin as therapy for Clostridium difficile infection in individuals taking concomitant antibiotics for other concurrent infections. Clin Infect Dis. 2011;53(5):440–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Zar FA, Bakkanagari SR, Moorthi KM, et al. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis. 2007;45(3):302–7.

    Article  CAS  PubMed  Google Scholar 

  14. McFarland LV, Elmer GW, Surawicz CM. Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol. 2002;97(7):1769–75.

    Article  CAS  PubMed  Google Scholar 

  15. Al-Nassir WN, Sethi AK, Nerandzic MM, et al. Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin. Clin Infect Dis. 2008;47(1):56–62.

    Article  PubMed  Google Scholar 

  16. Louie TJ, Miller MA, Mullane KM, et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med. 2011;364(5):422–31.

    Article  CAS  PubMed  Google Scholar 

  17. Ferrada P, Velopulos CG, Sultan S, et al. Timing and type of surgical treatment of Clostridium difficile-associated disease: a practice management guideline from the Eastern Association for the Surgery of Trauma. J Trauma Acute Care Surg. 2014;76(6):1484–93.

    Article  PubMed  Google Scholar 

  18. Stewart DB, Hollenbeak CS, Wilson MZ. Is colectomy for fulminant Clostridium difficile colitis life saving? A systematic review. Colorectal Dis. 2013;15(7):798–804.

    Article  CAS  PubMed  Google Scholar 

  19. Klobuka AJ, Markelov A. Current status of surgical treatment for fulminant Clostridium difficile colitis. World J Gastrointest Surg. 2013;5(6):167–72.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Neal MD, Alverdy JC, Hall DE, et al. Diverting loop ileostomy and colonic lavage: an alternative to total abdominal colectomy for the treatment of severe, complicated Clostridium difficile associated disease. Ann Surg. 2011;254(3):423–7 (discussion 7–9).

  21. Kelly CP. Can we identify patients at high risk of recurrent Clostridium difficile infection? Clin Microbiol Infect. 2012;18(Suppl 6):21–7.

    Article  PubMed  Google Scholar 

  22. Lo Vecchio A, Zacur GM. Clostridium difficile infection: an update on epidemiology, risk factors, and therapeutic options. Curr Opin Gastroenterol. 2012;28(1):1–9.

  23. Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis. 2011;53(10):994–1002.

    Article  PubMed  Google Scholar 

  24. Cammarota G, Ianiro G, Bibbò S, et al. Fecal microbiota transplantation: a new old kid on the block for the management of gut microbiota-related disease. J Clin Gastroenterol. 2014;48(Suppl 1):S80–4.

    Article  PubMed  Google Scholar 

  25. Youngster I, Russell GH, Pindar C, et al. Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. JAMA. 2014;312(17):1772–8.

    Article  CAS  PubMed  Google Scholar 

  26. Van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013;368(5):407–15.

    Article  PubMed  Google Scholar 

  27. Youngster I, Sauk J, Pindar C, et al. Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study. Clin Infect Dis. 2014;58(11):1515–22.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Kelly CR, Ihunnah C, Fischer M, et al. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Am J Gastroenterol. 2014;109(7):1065–71.

    Article  PubMed  Google Scholar 

  29. Johnston BC, Ma SS, Goldenberg JZ, et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis. Ann Intern Med. 2012;157(12):878–88.

    Article  PubMed  Google Scholar 

  30. Dumford DM 3rd, Nerandzic MM, Eckstein BC, et al. What is on that keyboard? Detecting hidden environmental reservoir of Clostridium difficile during an outbreak associated with North American pulsed-field gel electrophoresis type I strains. Am J Infect Control. 2009;37(1):15–9.

    Article  PubMed  Google Scholar 

  31. Siegel JD, Rhinehart E, Jackson M, et al. 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control. 2007;35(10 Suppl 2):S65–164.

    Article  PubMed  Google Scholar 

  32. Sethi AK, Al-Nassir WN, Nerandzic MM, et al. Persistence of skin contamination and environmental shedding of Clostridium difficile during and after treatment of C. difficile infection. Infect Control Hosp Epidemiol. 2010;31(1):21–7.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

    Consortia

    Adis Medical Writers

    Ethics declarations

    The article was adapted from Drugs and Aging 2015;32(8):639–47 [5] by salaried employees of Adis/Springer and was not supported by any external funding.

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Adis Medical Writers. Treat Clostridium difficile infection in the elderly based on disease severity and history of recurrence. Drugs Ther Perspect 32, 149–153 (2016). https://doi.org/10.1007/s40267-016-0279-4

    Download citation

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s40267-016-0279-4

    Keywords

    Search

    Navigation